P2 purinergic receptors: Modulation of cell function and therapeutic potential

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 3, 2000, Pages 862-869

  Burnstock, Geoffrey ^a   Williams, Michael ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; BRILLIANT BLUE; CIBACRON BLUE F3GA; GUANOSINE TRIPHOSPHATE DERIVATIVE; INOSITOL 1,4,5 TRISPHOSPHATE; PURINE P2 RECEPTOR; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; SURAMIN; URIDINE TRIPHOSPHATE;

ALLOSTERISM; APOPTOSIS; CELL METABOLISM; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; EPILEPSY; PRIORITY JOURNAL; REVIEW;

ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; BONE AND BONES; HEMOSTASIS; HUMANS; INSULIN; NEOPLASMS; RECEPTORS, PURINERGIC P2; SYNAPTIC TRANSMISSION;

EID: 0033680583     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Cystic fibrosis hetero- and homozygosity is associated with inhibition of breast cancer growth
2. Randomized clinical trial of adenosine 5'-triphosphate in patients with advanced non-small-cell lung cancer
3. P2 purine and pyrimidine receptors: Emerging superfamilies of G-protein coupled and ligand gated ion channel receptors
4. Pharmacological characterization of recombinant human and rat P2X receptor subtypes
5. Release of vasoactive substances from endothelial cells by shear stress and purinergic mechano-sensory transduction
6. P2X receptors in sensory neurons
7. Purinergic innervation of the guinea-pig urinary bladder
8. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X 3-deficient mice
9. 7 receptors
10. Receptors responsive to extracellular pyrimidine nucleotides
11. Distinct ATP receptors on pain-sensing and stretch-sensing neurons
12. - transport
13. Contribution of adrenergic and 'purinergic' neurotransmission to contraction in rabbit detrusor
14. 7 receptor of microglial cells: A novel immunomodulatory receptor
15. P2 purinergic receptors on osteoblasts and osteoclasts: Potential targets for drug development
16. Expression of multiple ATP subtypes during the differentiation and inflammatory activation of myeloid leukocytes
17. 2-purinergic receptors for extracellular ATP and other nucleotides
18. 1-deficient mice
19. Purines in anesthesia
20. 7 receptors by immunohistochemistry in rat stratified squamous epithelium
21. 3 purinoceptor and IB4 binding sites
22. Altered relaxant responses to adenosine and adenosine 5'-triphosphate in the corpus cavernosum from men and rats with diabetes
23. 2-purinoceptors to neurogenic contraction of rat urinary bladder smooth muscle
24. Physiological effects of extracellular nucleotidas in the inner ear
25. Induction of the P2Z/P2X7 nucleotide receptor and associated phospholipase C activity by lipopolysaccharide and IFN-γ in the human THP-1 monocytic cell line
26. P1 and P2 purine and pyrimidine receptor ligands
27. + ion fluxes in rat brain homogenates
28. Adenosine and ATP in epilepsy
29. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z (P2X7) receptors
30. P2X receptor immunoreactivity in the male genital organs of the rat
31. 1 receptor-null mice
32. P2 purinoceptor agonists: New insulin secretogogues potentially useful in the treatment of non-insulin-dependent diabetes mellitus
33. Diadenosine polyphosphates, extracellular function and catabolism
34. ATP is a potent stimulator of the activation and formation of rodent osteoclasts
35. 1 receptors
36. Frequent loss of expression or aberrant alternative splicing of P2XM, a p53-inducible gene, in soft tissue tumors
37. Trophic actions of extracellular nucleotides and nucleosidas on glial and neuronal cells
38. Adenosine diphosphate as an intracellular regulator of insulin secretion
39. Pharmacology of cloned P2X receptors
40. ATP and vasoactive intestinal polypeptide relaxant responses in hamster isolated proximal urethra
41. Therapeutic potential of nucleotides in the eye
42. Receptors for purines and pyrimidines
43. ATP in the treatment of cancer
44. Trophic effects of purines in neurons and glial cells
45. Ecto-protein kinases: Ectodomain phosphorylation as a novel target for pharmacological manipulation?
46. Emerging roles of purinergic signaling in gastrointestinal epithelial secretion and hepatobiliary function
47. P2 purinoceptor-mediated enhancement of Anti-IgE-stimulated human lung mast cell histamine release
48. Mutual occlusion of P2X ATP receptors and nicotinic receptors on sympathetic neurons of the guinea-pig
49. 7-independent mechanism
50. Cystic fibrosis gene and functions of CFTR implications of dysfunctional ion transport for pulmonary pathogenesis
51. Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation
52. Purinergic and pyrimidinergic receptors as potential drug targets
53. Effects of purines on rabbit corpus cavernosum contractile activity
54. Therapeutic use of nucleotidas in respiratory and ophthalmic diseases
55. Neural control of the lower urinary tract
56. Two novel families of ectonucleotidases: Molecular structures, catalytic properties and a search for function
57. Nucleotides and CD39: Principal modulatory players in hemostasis and thrombosis